|1.||D'Alessandro, R: 1 article (01/2008)|
|2.||Candelise, L: 1 article (01/2008)|
|3.||Vignatelli, L: 1 article (01/2008)|
|1.||Depressive Disorder (Melancholia)
05/13/1982 - "As part of an open multicentre study involving 22 psychiatric clinics 212 patients with depressive symptoms (predominantly endogenous depression) were treated over one month with viloxazine. "
01/01/1982 - "Viloxazine in the treatment of endogenous depression. "
03/01/1979 - "A double blind comparison of viloxazine and amitryptyline in involutional and endogenous depression."
01/01/1976 - "[Chemotherapy of melancholia by sequential neuroleptic-viloxazine association]."
03/01/1982 - "Viloxazine HCl in the treatment of endogenous depression: a standard (imipramine) controlled clinical study."
|2.||Alcoholism (Alcohol Abuse)
01/01/1990 - "Alcoholism and depression: a placebo controlled study with viloxazine."
01/01/1990 - "The results significantly favour viloxazine treatment in alleviating depression and in reducing alcohol abuse. "
09/01/1995 - "Studies of zimeldine, nialamide, L-dopa, viloxazine, and tetrabamate failed to demonstrate efficacy for these agents in the treatment of alcoholism. "
|3.||Major Depressive Disorder (Major Depressive Disorders)
03/01/1979 - "It is concluded that viloxazine is an effective antidepressant and particularly useful in the treatment of involutional depression."
01/01/1980 - "Involutional melancholia and the depressive phase of chronic psychosis constitute the best terms of viloxazine. "
05/01/1989 - "This report claims that combined viloxazine-piracetam is the most appropriate treatment for involutional depression. "
03/01/1979 - "Viloxazine and amitriptyline were equally effective in endogenous depression, but viloxazine was significantly more effective than amitriptyline in patients with involutional depression. "
09/01/1984 - "The occurrence of convulsions is not in keeping with the results of animal experiments and of clinical trials in which epileptic patients were included, both of which suggest that viloxazine does not have epileptogenic properties and may have anticonvulsant actions. "
03/16/1991 - "[Convulsive seizures under viloxazine therapy]."
09/01/1984 - "Six cases of convulsive seizures occurring during treatment with viloxazine notified to the Committee on Safety of Medicines (CSM) and two other cases from Japan were reviewed. "
01/01/1982 - "Viloxazine HCl is evaluated as an anticonvulsant in a wide range of rodent seizure models and in the epileptic baboon (Papio papio). "
07/09/1977 - "Convulsive seizures and viloxazine."
03/01/1979 - "Nausea and vomiting were the main side effect of viloxazine during early treatment necessitating the withdrawal of two patients. "
09/01/1977 - "Side effects reported with Viloxazine were predominantly nausea and dizziness of a transient nature. "
10/01/1997 - "The analysis of treatment emergent adverse events based on the UKU scale showed a higher frequency of nausea on day 14 and constipation at study end in the viloxazine group (p < 0.05) whereas reported weight gain (day 21) and concentration difficulty (day 21) were more frequently seen in the citalopram group (p < 0.05). "
01/01/1982 - "2 patients were discontinued due to adverse reactions; one for nausea and vomiting while receiving viloxazine and one for paroxysmal atrial tachycardia while receiving amitriptyline. "
06/06/1992 - "A miscellaneous group of novel antidepressants includes mianserin and trazodone (which both produce drowsiness) and viloxazine (which causes nausea). "
|3.||Levodopa (L Dopa)
|10.||Antidepressive Agents (Antidepressants)
|2.||Drug Therapy (Chemotherapy)